Innocare (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units under the 2023 Equity Incentive Plan to three grantees. These units represent approximately 0.87% of the company's total issued shares as of the announcement date, excluding treasury shares. The grant of restricted share units to the relevant executive director is conditional upon and subject to approval by shareholders at the upcoming Annual General Meeting.